Open AccessRequirements for human cardiomyocytes
Author(s) -
Yu Miao,
Lei Wei,
Cao Jiani,
Wang Lei,
Ma Aijin,
Zhao ZhenAo,
Yang HuangTian,
Shen Zhenya,
Lan Feng,
Cao Feng,
Liang Ping,
Pei Xuetao,
Xiang Andy Peng,
Yu Junying,
Zhang Yu,
Zhang Yong,
Li Qiyuan,
Zhou Jiaxi,
Wei Jun,
Peng Yaojin,
Zhu Huanxin,
Liang Lingmin,
Cao Nan,
Fu Boqiang,
Hao Jie,
Zhao Tongbiao,
Hu Shijun
Publication year - 2022
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/cpr.13150
Subject(s) - standardization , guideline , human use , china , preclinical testing , human cell , risk analysis (engineering) , test (biology) , business , computer science , microbiology and biotechnology , medicine , bioinformatics , biology , cell culture , pathology , political science , paleontology , genetics , law , operating system
‘Requirements for human cardiomyocytes', jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research, is the first guideline for human cardiomyocytes in China. This standard specifies the technical requirements, test methods, test regulations, instructions for use, labelling requirements, packing requirements, storage requirements, transportation requirements and waste disposal requirements for human cardiomyocytes, which is designed to normalize and standardize human cardiomyocyte research and production. It was originally released by the China Society for Cell Biology on 9 January 2021. We hope that the publication of this guideline will promote institutional establishment, acceptance and execution of proper protocols, and accelerate the international standardization of human cardiomyocytes for applications.